SCHEMBL16173527

SCHEMBL16173527

CC1CC(=O)N(CCCC(=O)NCCOCCOCCN=[N+]=[N-])C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CRBN Q96SW2 3/20 0.35
▸ PDE6D O43924 1/20 0.33
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ HDAC9 Q9UKV0 1/20 0.32
▸ HDAC5 Q9UQL6 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ ADORA3 P0DMS8 2/20 0.31
▸ ADORA2A P29274 2/20 0.31
▸ ADORA2B P29275 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23181275 0.89 SMN1; SMN2 (0.49) HPGDHTTSMN1; SMN2PDE6DHDAC3
SCHEMBL14870351 0.85 HTT (0.46) HPGDHTTSMN1; SMN2PDE6DHDAC3
SCHEMBL15146938 0.85 SMN1; SMN2 (0.46) HPGDHTTSMN1; SMN2PDE6DHDAC3
SCHEMBL13225533 0.83 SMN1; SMN2 (0.49) HPGDHTTSMN1; SMN2PDE6DHDAC3
SCHEMBL16870946 0.83 SMN1; SMN2 (0.42) HPGDHTTSMN1; SMN2HDAC3HDAC4
SCHEMBL19343049 0.83 SMN1; SMN2 (0.42) HPGDHTTSMN1; SMN2HDAC3HDAC4
SCHEMBL24686923 0.82 SMN1; SMN2 (0.62) HPGDHTTSMN1; SMN2HDAC3HDAC4
SCHEMBL14115871 0.82 MEN1 (0.34) HPGDHTTSMN1; SMN2HDAC3HDAC4
SCHEMBL22969982 0.82 SMN1; SMN2 (0.42) HPGDHTTSMN1; SMN2PDE6DHDAC3
SCHEMBL22710221 0.80 HPGD (0.45) HPGDHTTSMN1; SMN2PDE6DHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140309175-A1 POLYMERIC CONJUGATES OF C1-INHIBITORS BELROSE PHARMA INC (US) 2014-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309175-A1 POLYMERIC CONJUGATES OF C1-INHIBITORS SERPINC1, C1S, C1R HPGD 981/4885HTT 2206/4885SMN1; SMN2 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback